Tilray Brands (NASDAQ:TLRY) Shares Down 2.4% – What’s Next?

06 Jan 2026, 19:13 by Amy Steele · The Cerbat Gem

Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report)’s stock price was down 2.4% on Tuesday . The stock traded as low as $8.81 and last traded at $9.26. Approximately 7,112,328 shares changed hands during mid-day trading, an increase of 11% from the average daily volume of 6,401,877 shares. The stock had previously closed at $9.49.

Tilray Brands News Roundup

Here are the key news stories impacting Tilray Brands this week:

Positive Sentiment: New product pushes seasonal demand — Tilray launched expanded Dry January offerings (zero-proof spirits, non-alcoholic beers, hemp-derived delta-9 THC cocktails) and promoted its Mollo and XMG cannabis beverages, which could help top-line and beverage category momentum in Q2. Tilray Brands Expands Dry January Offerings
Positive Sentiment: Marketing push in Canada could support domestic sales — Campaigns targeting Dry January aim to convert on-trade and retail demand for non-alcohol and cannabis-infused beverages. Enhance Your Dry January with Mindful Sipping
Neutral Sentiment: Management sees beverage turnaround and wellness strength — Analysts note margin pressure in cannabis and CPG beverages, but company commentary suggests beverages and wellness brands could cushion results if execution holds. This moderates immediate downside but keeps the stock sensitive to beats/misses. Tilray Brands Readies for Q2 Earnings
Neutral Sentiment: Policy developments add ambiguity — Coverage considers the potential impact of federal rescheduling moves on Tilray’s long-term addressable market; outcome remains uncertain and could be either a catalyst or a non-event depending on implementation. Is Trump’s Cannabis Rescheduling Order Altering The Investment Case For Tilray Brands (TLRY)?
Negative Sentiment: Q2 earnings risk and margin pressure — Multiple previews warn Tilray faces margin headwinds in cannabis and beverages and is at a crossroads ahead of its fiscal Q2 2026 report; disappointing results or weak guidance would likely push the stock lower. Tilray Q2: High Hopes or Harsh Reality?
Negative Sentiment: Technical/short-term risk — Analysts note a “risky” chart pattern with a key date (Jan. 8) that could trigger volatility if earnings or news disappoint; recent big run-up in 2025 increases downside on a reversal. Tilray stock forms a risky pattern: Jan. 8 will be key

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Wall Street Zen raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Saturday, October 11th. Atb Cap Markets raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 10th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $20.00.

Check Out Our Latest Stock Report on TLRY

Tilray Brands Price Performance

The company has a current ratio of 2.62, a quick ratio of 1.56 and a debt-to-equity ratio of 0.15. The company has a fifty day moving average price of $10.45 and a two-hundred day moving average price of $10.48. The firm has a market cap of $1.04 billion, a P/E ratio of -0.41 and a beta of 1.77.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Silverlake Wealth Management LLC bought a new stake in shares of Tilray Brands during the third quarter worth $25,000. Oppenheimer & Co. Inc. acquired a new position in Tilray Brands in the 3rd quarter worth $25,000. Unified Investment Management bought a new position in Tilray Brands during the 3rd quarter worth about $26,000. J.W. Cole Advisors Inc. increased its holdings in Tilray Brands by 203.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock worth $30,000 after purchasing an additional 48,177 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Tilray Brands in the 3rd quarter valued at about $30,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Brands Company Profile

(Get Free Report)

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.